Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. 5000360005

Medchemexpress LLC Purinostat mesylate | 2650188-32-0 | 99.5% | 586.62 | 25 MG
SDP

Catalog No. 5000360005
Encompass_Preferred

Purinostat mesylate is a selective inhibitor of HDAC. It inhibits class I and class IIb HDACs with IC50s ranging from 0.81 to 11.5 nM. It induces apoptosis and affects the cell cycle of LAMA84 and 188 BL-2 cells, showing potent anti-leukemia effects in vivo. It is used for research on lymphoblastic leukemia.

  • Inhibits class I and class IIb HDACs
  • Induces apoptosis and affects cell cycle of LAMA84 and 188 BL-2 cells
  • Suppresses leukemia progression in vivo
  • Demonstrates potent anti-leukemia effects in BCR-ABL(T315I)-induced primary B-ALL mice

Catalog No. 50-003-60005 Supplier Medchemexpress LLC Supplier No. 25MGHY150109
May include imposed supplier surcharges.
Add to Cart
Add to Cart

missing translation for 'validMainframeMsg'

Purinostat mesylate is a selective inhibitor of HDAC. It inhibits class I and class IIb HDACs with IC50s ranging from 0.81 to 11.5 nM. It induces apoptosis and affects the cell cycle of LAMA84 and 188 BL-2 cells, showing potent anti-leukemia effects in vivo. It is used for research on lymphoblastic leukemia.

  • Inhibits class I and class IIb HDACs
  • Induces apoptosis and affects cell cycle of LAMA84 and 188 BL-2 cells
  • Suppresses leukemia progression in vivo
  • Demonstrates potent anti-leukemia effects in BCR-ABL(T315I)-induced primary B-ALL mice

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.